|
|
||||||||
Articles |
1
Division of Laboratory Medicine, Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114.
a Address correspondence to this author at: Room 235, Gray Bldg., Massachusetts General Hospital, Boston, MA 02114. Fax 617-726-3256; e-mail mlaposata{at}partners.org.
| Abstract |
|---|
|
|
|---|
Methods: An animal study was conducted in which test rats received injections of ethanol and control rats received injections of normal saline. The rats were killed 2 h after the injections. The bodies of the animals were stored at 4 °C up to 12 h, and samples of liver and adipose tissues were collected at different time intervals and processed for FAEE quantification. In another set of experiments, the rats received injections and were killed as described above, but bodies of animals from both groups were stored at 4, 25, or 37 °C for up to 72 h, and liver samples were collected and processed for FAEE quantification.
Results: FAEEs were detected up to 12 h after death in liver and adipose tissue samples from the bodies of ethanol-treated animals stored at 4 °C; negligible amounts were detected in the bodies of animals that received normal saline. Adipose tissues contained higher amounts of FAEEs than liver, as well as more species: eight FAEE species in adipose tissue and five in liver tissue. Higher concentrations of FAEEs were detected in livers of treated animals stored at 25 °C for up to 48 h than in livers of controls stored under the same conditions.
Conclusions: For at least 12 h after death, FAEEs in liver and adipose tissues are useful postmortem markers of premortem ethanol ingestion.
| Introduction |
|---|
|
|
|---|
We set out to determine whether FAEEs could be detected in two easily
accessible tissues of rats (liver and adipose) at autopsy and thereby
serve as markers of ethanol intake before death. We designed a control
study in which rats received injections of ethanol and then were
killed, and liver and adipose samples were collected at timed intervals
after death. It has been shown that FAEEs can be rapidly
degraded after uptake (9)(10); it
therefore was not known whether liver and adipose FAEEs from autopsy
specimens could be used as markers of premortem ethanol intake in
humans. Obviously, a controlled study with timing of a fixed ethanol
dose and fixed sample collection times after death cannot be performed
in humans. We chose the rat because there are published data showing
that FAEE metabolism is similar in rats and humans. Specifically, the
following have been shown: (a) the enzymatic
parameters for FAEE synthesis by acyl-CoA:ethanol
acyltransferase in human and rat liver microsomes are similar
(11)(12); (b) FAEEs and FAEE synthase
are found in rat and human adipose tissues after ethanol intake with a
similarly long half-life of
16 h after cessation of ethanol intake
(13)(14); (c) ethyl oleate as
a representative FAEE in both human and rat LDL is degraded similarly
by rat liver, and the oleate is directed after hydrolysis
toward triglycerides in both humans and rats
(10)(15); (d) ethyl oleate as a
representative FAEE within human LDL was degraded in both human and
rat blood over a 30-min incubation (10). FAEEs in
ethanol-exposed animals were detected in both liver and adipose for at
least 12 h after death, and the values were substantially higher
than the small amounts found in the liver and adipose of rats not
exposed to ethanol. This indicates that FAEEs in liver and adipose are
likely to be useful postmortem markers of ethanol intake before death.
| Subjects and Methods |
|---|
|
|
|---|
In another set of experiments, four SpragueDawley rats weighing 250300 g each were used. The experimental group consisted of two rats that received intraperitoneal injections of pure ethanol (2 g/kg) diluted with normal saline (1:1 by volume). The control group was two rats that received intraperitoneal injections of an equivalent volume of normal saline. The rats were killed by CO2 asphyxiation 2 h after injection. The bodies of the animals in the experimental and control groups were stored at 4, 25, or 37 °C for up to 72 h. Liver samples were removed for analysis from each rat 48 and 72 h after death. Liver samples were weighed (0.678 ± 0.036 g) and homogenized in phosphate-buffered saline as described above. Homogenate (1 mL) was extracted and analyzed for FAEE content.
faee isolation and quantification
FAEEs were isolated and quantified as described by Bernhardt et
al. (16) and Kaluzny et al. (17). A
50-µL (1 nmol) internal standard of ethyl heptadecanoate
(E17:0) was added to each sample. The samples were extracted
using acetone-hexane (2:8 by volume) and then dried under nitrogen to
300 µL. FAEEs were then isolated using solid-phase extraction with a
Bond Elute-LRC aminopropyl column (17). FAEEs were
quantified by gas chromatographymass spectrometry (GC-MS)
(18) using a Hewlett Packard 5890 Series II gas
chromatograph coupled to a Hewlett Packard 5971 mass spectrometer
equipped with a Supelcowax 10 capillary column. The oven temperature
was maintained at 150 °C for 2 min, increased to 200 °C at
10 °C/min and held for 4 min, increased to 240 °C at 5 °C/min
and held for 3 min, and then increased to 270 °C at 10 °C/min and
held for 5 min. The injector and mass spectrometer were maintained at
260 and 280 °C, respectively. The carrier gas flow rate was
maintained at a constant 0.8 mL/min throughout. Single-ion monitoring
was performed, quantifying appropriate base ions for individual FAEE
species [i.e., ions m/z 67, 88, and 101 for ethyl
palmitate (E16:0), ethyl heptadecanoate (E17:0), ethyl stearate
(E18:0), ethyl oleate (E18:1), and ethyl linoleate (E18:2); and ions
m/z 79 and 91 for ethyl arachidonate (E20:4), ethyl
eicosapentaenoate (E20:5), and ethyl docosahexaenoate (E22:6)]. FAEEs
were quantified by interpolation of the slope generated from
individually prepared calibration curves, comparing areas of various
concentrations of E16:0E22:6 to fixed concentrations of the internal
standard (E17:0). Mass relationships were obtained for each FAEE using
its individual calibration curve. Total FAEE mass was determined by the
addition of the masses of the individual FAEEs (E16:0E22:6).
| Results |
|---|
|
|
|---|
|
The individual species of FAEE in liver tissues, as a percentage of
total FAEEs over the same time course, are shown in Fig. 2
. The highest percentages were found for E16:0 and E18:0, which
accounted for
60% of the total FAEEs. There were five different
species of FAEEs detected in the liver.
|
The total amount of FAEEs in the adipose tissues stored at 4 °C was
10-fold higher (per gram of tissue) than was detected in the liver
tissues (Fig. 3
). This is most likely because FAEEs can be stored in
adipose tissue because they have hydrophobicity similar to that of
triglycerides. In addition, the FAEE concentrations in the adipose
tissues of animals exposed to ethanol were substantially higher
than the amounts found in animals not receiving ethanol. The controls
had values that approximated 0 nmol/g of adipose tissue, and the
animals treated with ethanol all had values on the order of 100 nmol/g
adipose tissue or higher. There was a decline in the amount of FAEE per
gram of tissue over the first 60 min after death, presumably because of
the postmortem hydrolysis of the FAEEs. This decline in FAEE
concentrations is not a confounding variable because the concentrations
of FAEEs that remained were far greater than those found in animals not
exposed to ethanol.
|
There were eight species of FAEEs identified in adipose tissue (Fig. 4
). The minor FAEE species were most likely detectable in adipose
because there was a much higher total FAEE concentration in
adipose tissue than in liver (13)(19). The major
FAEE species in adipose tissues were E18:1, E18:2, and E16:0,
accounting for
80% of the total FAEEs in the tissues. The other
five FAEE species in adipose tissues were present at lower
concentrations. E18:2 was a minor component of the ethyl esters in the
liver but a major component of the ethyl esters in the adipose tissues.
The molecular basis for the difference in fatty acid composition of the
FAEEs in liver and adipose tissues is not yet known.
|
In separate experiments, we determined that at 48 and 72 h after death, the amounts of FAEEs per gram of liver tissue in treated animals stored at 4 °C were eight- and fivefold higher than in the control group, respectively, as had been found in the initial studies. However, we also found that there was no overlap at 48 h between the controls and those treated with ethanol when the rats were stored at 25 °C (mean ± SE, 161 ± 19 nmol/g with ethanol vs 11 ± 2 nmol/g with no ethanol; P = 0.008; n = 2 per group). Presumably as a result of postmortem synthesis of ethanol by gut bacteria, there was synthesis of FAEE in the bodies of rats that did not receive ethanol intraperitoneally. No statistical differences in FAEE concentrations were detected between test (intraperitoneal ethanol) and control (no ethanol) groups stored at 25 °C for 72 h, at 37 °C for 48 h, and at 37 °C for 72 h.
| Discussion |
|---|
|
|
|---|
There is a need for better postmortem markers for ethanol intake. Currently, one of the major limitations is that the blood commonly used to measure blood ethanol is coagulated in subjects at autopsy. If peripheral blood is not available, heart blood may be obtained because it is less likely to be clotted, but the confounding variable of ethanol production by bacteria after death is introduced. Therefore, even if a sample is available for collection, the ethanol value may not reflect premortem ethanol intake. The confounding variable introduced by postmortem production of ethanol by bacteria necessitates additional testing for ethanol measurements in urine or vitreous humor. One of the major advantages for FAEEs in liver tissue as markers is their stability for 48 h after death when the body is stored at 4 or 25 °C. It is not yet known whether the particular FAEE species in liver or adipose tissues also provide diagnostically useful information. We previously demonstrated that E16:0 and E18:1 are the predominant FAEE species in the plasma, and the relative amounts of these two FAEE species are useful in separating chronic alcoholics from episodically excessive (binge) drinkers (19).
It is not clear why the FAEE species differ in liver and adipose tissues. It is presumed that the higher amount in adipose tissue reflects its ability to store large amounts of these hydrophobic molecules and that the liver is less equipped to collect large amounts of fat than is adipose tissue. We suspect that the half-lives for the FAEEs are higher in adipose tissue than in liver tissue, but this has not been studied for FAEEs in the liver. The half-life for FAEEs in adipose tissue is on the order of 16 h (13)(20). This would suggest that FAEEs in the adipose tissues, which we detected 2 h after ethanol intake was discontinued, would still be detectable if the ethanol intake was much longer than 2 h before death. Taken together, these results support the use of FAEEs in liver and in adipose tissue as postmortem markers of premortem ethanol intake.
| References |
|---|
|
|
|---|
The following articles in journals at HighWire Press have cited this article:
![]() |
R. Mancinelli and M. Ceccanti Biomarkers in Alcohol Misuse: Their Role in the Prevention and Detection of Thiamine Deficiency Alcohol Alcohol., March 1, 2009; 44(2): 177 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. O. SALEM, M. LAPOSATA, R. RAJENDRAM, J. E. CLUETTE-BROWN, and V. R. PREEDY THE TOTAL BODY MASS OF FATTY ACID ETHYL ESTERS IN SKELETAL MUSCLES FOLLOWING ETHANOL EXPOSURE GREATLY EXCEEDS THAT FOUND IN THE LIVER AND THE HEART Alcohol Alcohol., November 1, 2006; 41(6): 598 - 603. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Moore, J. Jones, D. Lewis, and K. Buchi Prevalence of Fatty Acid Ethyl Esters in Meconium Specimens Clin. Chem., January 1, 2003; 49(1): 133 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Refaai, P. N. Nguyen, T. S. Steffensen, R. J. Evans, J. E. Cluette-Brown, and M. Laposata Liver and Adipose Tissue Fatty Acid Ethyl Esters Obtained at Autopsy Are Postmortem Markers for Premortem Ethanol Intake Clin. Chem., January 1, 2002; 48(1): 77 - 83. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |